The primary disadvantage of AAV is its smaller packaging size for gene of interest, as well as a much later onset of expression (2-7 days for in vitro and 3-21 days for in vivo). However, this delivery system triggers very low levels of immune response.
Q What are limitations of AAV as a gene vector? There are two main limitations to AAV in my view. First, the DNA packaging capacity is innately restricted to 5KB. Beyond that limit, yields are reduced and DNA fragmentation causes the final preparation to lack homogeneity.
The other potential problem with using an AAV instead of a vent pipe is that if you ever get a blockage in the system that prevents the gasses from being pushed down into the sewer, those gases will have nowhere else to go.
These include platelet cells being depleted which could affect blood clotting, cells in the body being attacked, and even death through cardiogenic shock or the heart being put under too much stress from the immune response.
Host immune responses that limit durable therapeutic gene expression and cause clinically significant inflammation remain a major barrier to broadly successful development of adeno-associated virus (AAV)-based human gene therapies.
Genetic therapies hold promise to treat many diseases, but they are still new approaches to treatment and may have risks. Potential risks could include certain types of cancer, allergic reactions, or damage to organs or tissues if an injection is involved.
AAV vector genomes are been limited to 4.7 kb in length in order to balance the need for larger genetic constructs and effective payload delivery. Larger constructs can be attempted to be packaged in AAV vectors, however they are unlikely to be transfected and packaged enough to deliver the intended result.
Liver toxicity has been observed in both animal and humans following AAV administration. There is poor concordance between the liver toxicities observed in animals and humans.
How long does an AAV last? Adeno-associated viruses (AAVs) are stable for several months to years when stored properly at -80°C.
AAV Safety
AAV vectors are biosafety level 1, and consist of recombinant transgene sequences (e.g. marker or human genes) flanked by the AAV inverted terminal repeats. The removal of the majority of viral structural genes renders the vector replication-defective and dependent on an AAV helper virus.
Yes. Any AAV can malfunction or not operate properly because it is a mechanical device. Signs of that the Sure-Vent is not operating as intended, are foul odors.
Their lifespan can range from 10 years to 20 years and if they are starting to fail it may be time to replace them. Remember Air Admittance Valves are mechanical and do need to be replaced over time as routine maintenance.
The most accurate way to test an AAV is by using a manometer however this is not readily available. Another way is field testing in a cup of water, Place the air admittance valve (AAV) in a cup as shown below. This creates a positive pressure which seals the membrane and allows the valve to float.
AAV1, AAV2, and AAV8 were shown to be most stable at pH 5.5 while AAV5 was most stable at pH 7.5. The temperature at which VP1u is externalized differed between the viruses, consistent with differences in capsid stability.
Disadvantages and risks of using the retrovirus as a viral vector in gene therapy include low transduction efficiency, replication competence, insert size, integration, inactivation by complement cascade, and the requirement of cell division for transduction.
Genomic Architecture Differences:
These ITRs are essential for packaging the therapeutic gene into the AAV capsid and facilitating its transduction into target cells. Lentiviral plasmids do not have these ITRs, so a plasmid designed for AAV cannot be directly used for lentivirus without removing the ITRs.
I have had plumbers tell us that sewer flies and bugs have been seen at failed air admittance valves. So if you detect a sewer odor under and around your sink or in the attic, the AAV could have let you down.
AAV particles are stable for long time (almost indefinitely) at -80°C. Storage at -20°C is not recommended. At 4°C the virus is stable for several days, but is said to loose about 50% of infectious titer after 1 month.
The Studor vent lets that air to be sucked in the pipe during water flow but doesn't let sewer gas escape out. Code is the thing that determines pipe size and also water flow. Hence no studor vents are permitted to toilets because more air is required to keep water flow going with more waste added to the toilet.
Recombinant AAV administration, including serotypes, promoters, and enhancers, can cause side effects such as genotoxicity, carcinogenesis, liver damage, thrombotic microangiopathy, and microvascular thrombosis.
In mice, many AAV serotypes can target the liver with high efficiency, particularly AAV8, AAV7 and AAV9. However, this is not universal and may be very different from one species to another. While AAV8 has been used extensively for human liver gene therapy, it may not be the best serotype for human hepatocytes.
AAV vectors can efficiently transduce primary neurons in vitro (see above) but the toxicity of AAV vectors on primary neurons and glia in vitro has not been well characterized. One of the features that makes rAAV vectors a desired vector for gene therapy in the brain is the low toxicity and immunogenicity.
Recombinant, AAV-derived vector particles that contain no nucleic acid sequences of AAV except for the ITRs and no potentially hazardous nucleic acid fragment, even if these are pseudotyped, are allocated to risk group 1. The classification is irrespective of which AAV the ITRs used originate from.
AAV location
It must be located a minimum of 4” above the horizontal branch drain, 6” above any insulation material and within 15 degrees of vertical. AAVs cannot be permanently covered and should be installed in an area that allows air to enter the valve.
showed that an AAV vector would continue to express its transgene for 6–12 months in vivo. Subsequently, expression from an AAV vector in a canine eye persisted unabated for up to 12 years (William Hauswirth, unpublished), and similar results have been reported for muscle and brain transductions.